CordenPharm Transfers Amino Acid Product Portfolio to CU Chemie Uetikon

By Supplier News - DCAT Publisher

February 24, 2014

CordenPharma Switzerland LLC reports that its active pharmaceutical Ingredient manufacturing facility in Liestal, Switzerland has transferred its entire amino acid building blocks product portfolio to CU Chemie Uetikon GmbH, based in Lahr, Germany, effective February 1, 2014.

CordenPharma Switzerland had identified Chemie Uetikon as an partner for larger-scale manufacturing of amino acid building blocks. As a result of the transfer, CordenPharma Switzerland will now focus on growing its core peptide synthesis and specialized ingredient manufacturing capabilities such as carbohydrates and synthetic lipids. Chemie Uetikon will take over the amino acid building blocks business from CordenPharma Switzerland and market them to clients globally. CordenPharma Switzerland will continue to manufacture and market pseudoproline building blocks using proprietary technology.

 Source: Corden Pharma